Dr. Chris E. Freise, MD

Dr. Freise practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Freise's NPI, 1194780775, was assigned on April 18, 2006. Dr. Freise graduated from University Of Minnesota Medical School in 1986. Dr. Freise holds California license G65942.

Dr. Freise's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Freise's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Freise to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freise practices. Vendor and product names are available with a free account.

Surgery is Dr. Freise's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Freise is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Freise's licenses on file in 2 states: California and Minnesota.

Dmand AI lists kidney transplant among the conditions Dr. Freise treats.

CMS data shows 177 Medicare services from Dr. Freise across 8 procedure codes in 2024, for 121 Medicare patients. Medicare paid $71,353 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Dr. Freise in 2026. The largest group is under 65, with 54 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 47% are also on Medicaid. Their average risk score is 7.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Freise's median patient age at 63, with 49% women.

In 2026, Dr. Freise wrote 225 Medicare Part D claims for 38 patients. 91% of them were for generic drugs. CMS names the drug for 125 of them, across 6 drugs with 11 or more claims each, at $4,440 in total drug cost. In 2023, CMS named 84 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Freise for performance year 2026, reported as part of a group. Dr. Freise accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Freise as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 111 papers to Dr. Freise, published from 2006 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Liver Transplantation, Kidney Transplantation and Living Donors. Dr. Freise has published most often in Transplantation. Dr. Freise's most frequent co-authors are Nancy L. Ascher, MD, Peter G. Stock, MD and John P. Roberts, MD.

Dmand AI links Dr. Freise to 2 clinical trials. Conditions studied include End Stage Liver Disease, Hernia, Ventral and Liver Failure.

CMS Open Payments shows 12 general payments to Dr. Freise from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $454.

Dmand AI lists 3 awards for Dr. Freise, most recently ACS Fellow in 2013.

Dr. Freise graduated from University Of Minnesota Medical School in 1986. Dr. Freise is a member of ACS.

Dr. Freise is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.